Grants

#2019 Sponsored Research Agreement Title: Novel peptide-based therapies for the treatment of diabetes - 2019 agreement
Start: 01-01-2020 / End: 12-31-2022 Primary Investigators: Diego Perez-Tilve Investigators: Perez-Tilve, Diego Grant Sponsor: Novo Nordisk A/S Grant Amount: $1,309,722.08 (level: Foreign Industry)

#R01GM144426 Title: Mechanistic role of phosphatidylinositol 5-phosphate 4-kinase beta in GTP-dependent lysosomal acidification for stress-resilient cell growth and metabolism
Start: 12-15-2022 / End: 11-30-2026 Investigators: Perez-Tilve, Diego; Sasaki, Atsuo Grant Sponsor: National Institute of General Medical Sciences Grant Amount: $372,318.00 (level: Federal)

#IBRI Service Agr Title: Development of multi receptor agonists from the treatment of metabolic diseases.
Start: 10-01-2024 / End: 03-31-2025 Primary Investigators: Diego Perez-Tilve Grant Sponsor: Indiana Biosciences Research Institute Grant Amount: $104,279.27

#IBRI Service Agr Title: Development of multi receptor agonists from the treatment of metabolic diseases.
Start: 10-01-2024 / End: 03-31-2025 Primary Investigators: Diego Perez-Tilve Grant Sponsor: Indiana Biosciences Research Institute Grant Amount: $104,279.27

#IBRI Service Agr Title: Development of multi receptor agonists from the treatment of metabolic diseases.
Start: 09-01-2025 / End: 12-31-2025 Primary Investigators: Diego Perez-Tilve Grant Sponsor: Indiana Biosciences Research Institute Grant Amount: $118,013.50 (level: Non Profit)

#IBRI Service Agr Title: Development of multi receptor agonists from the treatment of metabolic diseases.
Start: 09-01-2025 / End: 12-31-2025 Primary Investigators: Diego Perez-Tilve Grant Sponsor: Indiana Biosciences Research Institute Grant Amount: $118,013.50 (level: Non Profit)